Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Longevity Health Holdings, Inc. (XAGE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: XAGE (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -74.85% | Avg. Invested days 44 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 2.20 - 59.70 | Updated Date 06/3/2025 |
52 Weeks Range 2.20 - 59.70 | Updated Date 06/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Longevity Health Holdings, Inc.
Company Overview
History and Background
Longevity Health Holdings, Inc. is a relatively young company founded to focus on value-based care within the senior healthcare market. Details on the exact founding year and early milestones are limited in public sources, suggesting the company has grown organically and through strategic partnerships.
Core Business Areas
- Medicare Advantage Plans: Offers Medicare Advantage plans focusing on chronic disease management and integrated care models. Services include medical, pharmacy, and supplemental benefits.
- Value-Based Care Programs: Partners with providers to implement value-based care models, emphasizing preventative care and care coordination to improve health outcomes and reduce costs.
- Chronic Disease Management: Provides specialized programs and services to manage chronic conditions common among seniors, such as diabetes, heart disease, and respiratory illnesses.
Leadership and Structure
Information on the specific leadership team and organizational structure is limited. Given the company's focus on value-based care, expect a structure supporting provider partnerships and integrated care delivery.
Top Products and Market Share
Key Offerings
- Medicare Advantage Plans: Longevity Health offers Medicare Advantage plans primarily focused on chronic care. Market share data for Longevity Health is not readily available. Competitors include UnitedHealth (UNH), Humana (HUM), and CVS Health (CVS) which own large Medicare Advantage providers, such as Aetna.
- Value-Based Care Programs: The Value-Based care business delivers services to insurance companies and hospital networks. Competitors include Signify Health (CVS), Evolent Health (EVH), and Privia Health Group (PRVA).
Market Dynamics
Industry Overview
The healthcare industry, particularly the senior care segment, is experiencing rapid growth driven by an aging population and increasing prevalence of chronic diseases. Value-based care is gaining traction as a strategy to improve outcomes and reduce costs.
Positioning
Longevity Health Holdings, Inc. is positioned as a provider focused on value-based care for seniors, emphasizing chronic disease management and integrated care models. Its competitive advantage lies in its specialized expertise and focus on this niche market.
Total Addressable Market (TAM)
The total addressable market for Medicare Advantage is estimated to be in the hundreds of billions of dollars, with a significant portion related to chronic care management. Longevity Health Holdings, Inc. is positioned to capture a portion of this TAM through its specialized offerings and value-based care approach.
Upturn SWOT Analysis
Strengths
- Focus on value-based care models
- Expertise in chronic disease management
- Partnerships with providers
- Specialized focus on senior healthcare
Weaknesses
- Limited brand recognition
- Smaller scale compared to larger competitors
- Dependence on provider partnerships
- Limited publicly available financial data
Opportunities
- Expansion of Medicare Advantage plans
- Growth in value-based care adoption
- Partnerships with larger healthcare organizations
- Technological advancements in chronic disease management
Threats
- Regulatory changes in Medicare Advantage
- Increased competition from larger players
- Changes in provider reimbursement models
- Economic downturn affecting healthcare spending
Competitors and Market Share
Key Competitors
- UNH
- HUM
- CVS
- EVH
- PRVA
Competitive Landscape
Longevity Health Holdings, Inc. faces significant competition from larger, more established players in the Medicare Advantage and value-based care markets. Its advantages lie in its specialized focus and expertise, but it needs to scale its operations and build brand recognition to compete effectively.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is difficult to determine due to a lack of publicly available financial data.
Future Projections: Future growth projections are unavailable due to a lack of publicly available financial data. Any projection would be speculative.
Recent Initiatives: Details on recent strategic initiatives are limited due to a lack of public information.
Summary
Longevity Health Holdings, Inc. is a specialized healthcare provider focusing on value-based care for seniors, particularly chronic disease management, in the Medicare Advantage market. While they face competition from established players, their focused approach presents opportunities for growth. Financial information is limited, making it difficult to assess their financial strength fully. They must focus on scaling to compete effectively.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company websites
- Industry reports
- News articles
- Analyst reports (limited access)
Disclaimers:
The information provided is based on publicly available data and limited analyst estimates. Financial data is incomplete. This analysis is for informational purposes only and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Longevity Health Holdings, Inc.
Exchange NASDAQ | Headquaters Pittsburgh, PA, United States | ||
IPO Launch date 2021-09-23 | CEO & Executive Chairman Mr. Rajiv Sarman Shukla | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 13 | Website https://www.carmellcosmetics.com |
Full time employees 13 | Website https://www.carmellcosmetics.com | ||
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.